Want to see ELV full AI Analyst Report?
ELV Stock Chart & Stats
$398.87
-$1.63(-0.43%)
At close: 4:00 PM EDT
$398.87
-$1.63(-0.43%)
Day’s Range― - ―
52-Week Range$274.84 - $436.24
Previous CloseN/A
Volume969.56K
Average Volume (3M)904.64K
Market Cap
$86.08B
Enterprise Value$115.45K
Total Cash (Recent Filing)$37.51B
Total Debt (Recent Filing)$31.04B
Price to Earnings (P/E)18.5
Beta0.45
Next Earnings
Oct 21, 2026EPS Estimate
4.66Next Dividend Ex-DateN/A
Dividend Yield1.65%
Share Statistics
EPS (TTM)22.50
Shares Outstanding216,869,300
10 Day Avg. Volume886,804
30 Day Avg. Volume904,640
Financial Highlights & Ratios
PEG Ratio-5.70
Price to Book (P/B)1.77
Price to Sales (P/S)0.39
P/FCF Ratio24.50
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$444.93Price Target Upside11.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
EPS Forecast (FY)27.15
Revenue Forecast (FY)$197.09B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthElevance is expanding its revenue base at a strong rate, indicating continued demand across its health benefits and services platforms. Sustained top-line growth can increase operating scale, support investment in capabilities, and strengthen the company’s ability to absorb cost pressure over the next several quarters.
Positive Cash GenerationSubstantial operating and free cash flow provide internal funding for technology, care management, capital needs, and shareholder returns without relying entirely on external financing. Although cash conversion has been uneven, the underlying ability to generate billions in cash supports financial resilience and execution.
Carelon Platform ScalingCarelon adds a services-oriented growth engine alongside Elevance’s insurance operations, while demonstrated savings support its value to health plans and customers. Scaling integrated medical, pharmacy, behavioral, and home-based offerings could diversify revenue and improve medical-cost management over time.
Bears Say
Margin CompressionThe decline in profitability indicates that rapid revenue growth is not translating proportionally into earnings, increasing sensitivity to medical utilization and operating execution. Persistently lower margins could constrain reinvestment capacity and make future earnings more dependent on pricing, cost control, and favorable claims performance.
Medicaid Pressure And ExitsLoss-making Medicaid operations directly weigh on consolidated profitability and may reduce membership as the company exits markets where sustainable performance is not achievable. While portfolio discipline can improve results later, the restructuring and attrition create a continuing earnings and scale headwind over the medium term.
Elevated Medical UtilizationConcentrated utilization increases can raise benefit costs faster than premiums or contract rates, pressuring medical margins across affected products. Management describes these trends as actionable, but sustained intensity would require effective care management, pricing, and network responses and could keep expenses elevated through the next several quarters.
Elevance Health News
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $274.84 and its highest was $436.24 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $86.08B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Oct 21, 2026 which is in 39 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Jul 15, 2026. The company reported $7.45 earnings per share for the quarter, beating the consensus estimate of $6.211 by $1.239.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.72 which represents an annual dividend yield of 1.65%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 4.66.
How many shares outstanding does Elevance Health have?
Elevance Health has 216,869,300 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $7.45 in its last earnings report, beating expectations of $6.211. Following the earnings report the stock price went down -8.543%.
Which hedge fund is a major shareholder of Elevance Health?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$444.93 (11.55% Upside)
$444.93 (11.55% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 74%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Decreased
By 254.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.3%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Very Bullish
Bullish news 89%
Bearish news 11%
Bearish news 11%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.49%
12-Months-Change
Fundamentals
Return on Equity
1.65%
Trailing 12-Months
Asset Growth
3.69%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Elevance Health
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
ELV Company Deck
ELV Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was broadly constructive: management reported a quarter that beat expectations, raised 2026 EPS guidance, increased operating cash flow guidance, and highlighted scalable growth drivers (Medicare Advantage improvement, Carelon expansion, and technology-enabled cost management). Notable headwinds remain in Medicaid (projected -1.75% margin), concentrated utilization trends (behavioral health, specialty pharmacy, outpatient surgery, ED), planned market exits, and near-term investments that keep expense ratios elevated. Management emphasized prudence and one-time uses of the Q2 benefit while articulating confidence in returning to at least 12% adjusted EPS growth in 2027 based on diversified levers across the enterprise.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$444.93
▲(11.55% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
27.40% Mutual Funds
25.39% Other Institutional Investors
23.40% Public Companies and Individual Investors